Hypromellose, ethykellulose, and polyethylene oxide use in hot melt extrusion

Pharmaceutical Technology

Volumn 30, Issue 1, 2006, Pages 62-70

  Coppens, Karen A ^a   Hall, Mark J ^a   Mitchell, Shawn A ^a   Read, Michael D ^a  

^a DOW CHEMICAL COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELTING; METAL EXTRUSION; POLYMERS; PROCESS CONTROL;

ETHYKELLULOSE; HOT MELT EXTRUSION (HME); HYPROMELLOSE;

POLYETHYLENE OXIDES;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BUTYLCRESOL; CHLORPHENIRAMINE MALEATE; CLOTRIMAZOLE; DRUG ADDITIVE; ETHYL CELLULOSE; HYDROCHLOROTHIAZIDE; HYDROXYPROPYLMETHYLCELLULOSE; ITRACONAZOLE; KETOPROFEN; MACROGOL; PLASTICIZER; POLYCARBOPHIL; POLYMER; PROPRANOLOL; THEOPHYLLINE;

DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; GEL PERMEATION CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; REVIEW; TENSILE STRENGTH; THERMOSTABILITY; VISCOSITY; X RAY DIFFRACTION;

EID: 31344450582     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. I. Ghebre-Sellassie and C. Martin, Eds. Pharmaceutical Extrusion Technology (Marcel Dekker, Inc., New York, NY, 2003).
2. J. Breitenbach, "Melt Extrusion: from Process to Drug Delivery Technology," Eur. J. Pharm. Biopharm. 54 (2), 107-117 (2002).
3. S. Sethia and E. Squillante, "Solid Dispersions: Revival with Greater Possibilities and Applications in Oral Drug Delivery," Critical Reviews in Therapeutic Drug Carrier Systems, 20 (2,3), 215-247 (2003).
4. J. McGinity, "Hot-Melt Extrusion as a Pharmaceutical Process," AAPS Newsmagazine, 7 (3), 21-25 (2004).
5. J. McGinity et al. "Hot-elt Extrusion as a Pharmaceutical Process," Amer. Pharm. Rev. 4 (2), 25-36 (2001).
6. I. Ghebre-Sellassie and C. Martin, Eds. Pharmaceutical Extrusion Technology (Marcel Dekker, Inc., New York, NY, 2003).
7. J. Brydson, Flow Properties of Polymer Melts, Second Edition (George Godwin Limited, London, UK, 1981).
8. C. Han, Rheology in Polymer Processing (Academic Press, New York, NY, 1976).
9. R. Gächter and H. Müller, Eds., Plastics Additives Handbook (Hanser Publishers, Munich, Germany, 1983).
10. J. Sears and J. Darby, The Technology of Plasticizers (John Wiley & Sons, New York, NY, 1982).
11. C. DeBrabander et al. "Characterization of Ibuprofen as a Nontraditional Plasticizer of Ethyl Cellulose," J.Pharm. Sci. 91 (7), 1678-1685 (2002).
12. B. Rambali et al. "Itraconazole Formulation Studies of the Melt-Extrusion Process with Mixture Design," Drug De v. Ind. Pharm. 29 (6), 641-652 (2003).
13. J. McGinity, "Hot-Melt Extrudable Pharmaceutical Formulation," US Patent No. 6,488,963 B1, Dec. 3, 2002.
14. W. Miller, R. Shaw, and P. King, "The Facile Extrusion of Ethylene Oxide Resins Has Been Effected by Employing Water as an Extrusion Aid," US Patent No. 3,941,865, March 2, 1976.
15. L. Burrows, W. Lawson, and C. Van Winter, "Extrusion Method for Organic materials," US Patent No. 2,257,104A, Sept. 30, 1941.
16. D. Chalasani and R. Johnson, "Method for Rapid Stiffening of Extrudates," US Patent No. 5,966,582A, Oct. 12, 1999.
17. K. Coppens et al. "Thermal and Rheological Evaluation of Pharmaceutical Excipients for Hot Melt Extrusion," paper presented at the 2004 AAPS Annual Meeting and Exposition, Baltimore, MD.
18. M. Repka and J. McGinity, "Influence of Vitamin E TPGS on the Properties of Hydrophilic Films Produced by Hot-Melt Extrusio," Int. J. Pharm. 202 (1-2), 63-70 (2000).
19. M. Crowley, et al. "Stability of Polyethylene Oxide in Matrix Tablets Prepared by Hot-Melt Extrusion," Biomaterials 23 (21), 4241-4248 (2002).
20. F. Zhang and J. McGinity, "Properties of Sustained-Release Tablets Prepared by Hot-Melt Extrusion," Pharm. Dev. Technol. 42 (2), 241-250 (1999).
21. M. Repka, S. Prodduturi, and S. Stodghill, "Production and Characterization of Hot-Melt Extruded Films Containing Clotrimazole," Drug Dev. Ind. Pharm. 29 (7), 757-765 (2003).
22. D. Schachter, et al. "Solid Solution of a Poorly Soluble Model Drug in a Phase-Separated Polymer Matrix: Melt-Prepared Dispersions based on POLYOX WSR," presented at the 30th Annual Meeting of the Controlled Release Society, Glasgow, Scotland, July 2003.
23. D. Schachter, et al. "Solid-State Nuclear Magnetic Resonance Characterization of Melt-Prepared Dispersions Based on POLYOX WSR," presented at the 30th Annual Meeting of the Controlled Release Society, Glasgow, Scotland, July 2003.
24. C. DeBrabander, C. Vervaet, and J.P. Remon, "Development and Evaluation of Sustained Release Mini-Matrices Prepared via Hot Melt Extrusion," J. Controled Release 89 (2), 235-247 (2003).
25. C. DeBrabander, et al. "Bioavailability of Ibuprofen From Hot-Melt Extruded Mini-Matrices," Int. J. Pharm. 271 (1-2), 77-84 (2004).
26. M. Crowley, et al. "Physicochemical Properties and Mechanism of Drug Release from Ethyl Eellulose Matrix Tablets Prepared by Direct Compression and Hot-Melt Extrusion," Int. J. Pharma. 269 (2), 509-522 (2004).
27. D. Alderman and T. Wolford, "Sustained Release Dosage Form based on Highly Plasticized Cellulose Ether Gels," US Patent No. 4,678,516, July 7, 1987.
28. G. Verreck, et al. "Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion-Part I," Int. J. Pharm. 251 (1-2) 165-174 (2003).
29. K. Six, H. Berghmans, et al. "Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion, Part II," Pharm. Res. 20 (7), 1047-1054 (2003).
30. E. Mehuys, C. Vervaet, and J. Remon, "Hot-Melt Extruded Ethyl-cellulose Eylinders Containing a HPMC-Gelucire Core for Sustained Drug Delivery," J. Controled Release 94 (2-3), 273280 (2004).
31. E. Mehuys, et al. "In Vitro and in Vivo Evaluation of a Matrix-in-Cylinder System for Sustained Drug Delivery," J. Controled Release 96 (2), 261-271 (2004).